The new weight loss medication, Qsymia, is now available. This is a brand item and is currently only available through a few distribution channels. In addition to the high cost, this product has significant restrictions and warnings. Since Qsymia is a combination of Phentermine and Topamax, most bariatric physicians are dispensing these two medications to their patients in the generic form.
The other new weight loss product, Belviq (lorcaserin hcl), is still not available. The DEA is recommending this drug be classified as a schedule IV controlled substance.
Lannett has discontinued manufacturing their Hydrochlorothiazide 25mg and 50mg tablets. We now carry another manufacturer and are offering their product at a slightly lower price. Please call us for product information.